Adicet Bio, Inc. Operating Lease Right-of-Use Assets
Adicet Bio, Inc. (ACET) had Operating Lease Right-of-Use Assets of $9.54 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-05
- 2026-06-30: Operating Lease, Right-of-Use Asset $9.54M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $10.24M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $10.93M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $11.90M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $9.54M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $10.24M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $10.93M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $11.90M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $12.55M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $13.38M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $14.23M 10-K · filed 2026-03-12 |
| 2024-09-30 | $15.05M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $15.86M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $16.65M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $17.42M 10-K · filed 2025-03-06 |
| 2023-09-30 | $18.18M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $18.93M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $19.71M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $20.27M 10-K · filed 2024-03-19 |
| 2022-09-30 | $20.99M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $21.40M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $19.71M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $20.36M 10-K · filed 2023-03-15 |
| 2021-09-30 | $20.86M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $21.69M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $22.38M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $23.07M 10-K · filed 2022-03-15 |
| 2020-01-01 | $1.40M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |